Search research articles
Contact Us
Filters
Showing results (1-10 of 262) with videos related to
Page
of 27
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 9, 2020
From Compassionate Use to Phase 3 Trial: The Impact of Germany's PSMA-617 Literature
Thomas A Hope
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2020
Updates to the Appropriate-Use Criteria for Somatostatin Receptor PET
Thomas A Hope
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 4, 2024
PSMA PET AUC Updates: Inclusion of rh-PSMA-7.3
Thomas A Hope, Hossein Jadvar
JAMA Oncology
|
February 17, 2022
PSMA PET in Prostate Cancer-A Biomarker or a Surrogate End Point?-Reply
Thomas A Hope, Jeremie Calais
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 2022
Leadership in Patient Advocacy: A Conversation Between Josh Mailman and Thomas Hope
Josh Mailman, Thomas A Hope
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 6, 2021
RESIST-PC: U.S. Academic Foray into PSMA Theranostic Trials
Amir Iravani, Thomas A Hope
Lancet (London, England)
|
February 14, 2021
PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer
Thomas A Hope, Jeremie Calais
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 29, 2022
Updates to Appropriate Use Criteria for PSMA PET
Thomas A Hope, Hossein Jadvar
Journal of the American College of Cardiology
|
December 3, 2011
Improved risk assessment for abdominal aortic aneurysm rupture: off-the-wall imaging
Thomas A Hope, Michael D Hope
Current Opinion in Cardiology
|
September 14, 2013
Functional and molecular imaging techniques in aortic aneurysm disease
Michael D Hope, Thomas A Hope
Page
of 27
Search research articles
Search
Showing results (1-10 of 262) with videos related to
Sort By:
Page
of 27
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 9, 2020
From Compassionate Use to Phase 3 Trial: The Impact of Germany's PSMA-617 Literature
Thomas A Hope
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2020
Updates to the Appropriate-Use Criteria for Somatostatin Receptor PET
Thomas A Hope
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 4, 2024
PSMA PET AUC Updates: Inclusion of rh-PSMA-7.3
Thomas A Hope, Hossein Jadvar
JAMA Oncology
|
February 17, 2022
PSMA PET in Prostate Cancer-A Biomarker or a Surrogate End Point?-Reply
Thomas A Hope, Jeremie Calais
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 2022
Leadership in Patient Advocacy: A Conversation Between Josh Mailman and Thomas Hope
Josh Mailman, Thomas A Hope
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 6, 2021
RESIST-PC: U.S. Academic Foray into PSMA Theranostic Trials
Amir Iravani, Thomas A Hope
Lancet (London, England)
|
February 14, 2021
PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer
Thomas A Hope, Jeremie Calais
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 29, 2022
Updates to Appropriate Use Criteria for PSMA PET
Thomas A Hope, Hossein Jadvar
Journal of the American College of Cardiology
|
December 3, 2011
Improved risk assessment for abdominal aortic aneurysm rupture: off-the-wall imaging
Thomas A Hope, Michael D Hope
Current Opinion in Cardiology
|
September 14, 2013
Functional and molecular imaging techniques in aortic aneurysm disease
Michael D Hope, Thomas A Hope
Page
of 27